Coherus Oncology (CHRS) Short term Debt (2013 - 2024)
Coherus Oncology's (CHRS) quarterly Short term Debt came in at $175.0 million in Q1 2024, up 5203.03% quarter-over-quarter from $3.3 million in Q4 2023.
Powered by 
Analysis
Coherus Oncology (CHRS) Short term Debt (2013 - 2024) Analysis & Trends
Coherus Oncology has disclosed Short term Debt across 10 years of filings, most recently posting $175.0 million for Q1 2024.
- In Q1 2024, Short term Debt changed N/A year-over-year to $175.0 million; the TTM figure through Mar 2024 stood at $175.0 million (changed N/A YoY), while the FY2023 annual figure was $3.3 million, changed N/A from the prior year.
- Short term Debt came in at $175.0 million for Q1 2024 at Coherus Oncology, up from $3.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $175.0 million in Q1 2024 to a low of $3.3 million in Q4 2023.
- Average Short term Debt over 3 years is $42.2 million, with a median of $11.5 million recorded in 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Coherus Oncology | 209.00 Mn | 103.70 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 175.00 Mn |
| Dec 31, 2023 | 3.30 Mn |
| Sep 30, 2023 | 4.04 Mn |
| Sep 30, 2021 | 17.31 Mn |
| Jun 30, 2021 | 11.54 Mn |
| Jun 30, 2019 | 50,000.00 |
| Mar 31, 2018 | 3.50 Mn |
| Dec 31, 2017 | 3.29 Mn |
| Sep 30, 2017 | 2.76 Mn |
| Jun 30, 2017 | 388,000.00 |
| Mar 31, 2017 | 5.94 Mn |
| Dec 31, 2016 | 5.55 Mn |
| Sep 30, 2016 | 4.99 Mn |
| Jun 30, 2016 | 6.57 Mn |
| Mar 31, 2016 | 3.49 Mn |
| Dec 31, 2015 | 3.55 Mn |
| Sep 30, 2015 | 3.09 Mn |
| Jun 30, 2015 | 5.51 Mn |
| Mar 31, 2015 | 3.72 Mn |
| Dec 31, 2014 | 5.71 Mn |